Takeda Ireland Limited

Home page : 
http://www.takeda.ie/

Business : 
Production

Address : 
TIL(Bray), Bray Business Park, Kilruddery, Co. Wicklow, Ireland TIL(Grange Castle), Grange Castle Business Park, Dublin 22, Ireland

Telephone Number :
+353-1205-0600 (Bray) / +353-1467-2400 (Grange Castle)

Fax Number : 
+353-1205-0601 (Bray) / +353-1467-2401 (Grange Castle)

Founded :
1997

Contact :
bray@takeda.ie 
grangecastle@takeda.ie

Takeda Ireland Limited (TIL) has played a key role in Takeda's worldwide operations since October 1997. We began manufacturing in Bray, Co. Wicklow, Ireland following the opening of our custom built premises in 1999. Since the first shipment of Blopress/Amias in September 1999, TIL has manufactured Takeda's strategic solid oral dosage formulations for worldwide markets.

In 2002 Takeda decided to locate its overseas manufacturing centre for Active Pharmaceutical Ingredients (API). This operation licensed key products and took responsibility for activities from research, development and manufacturing through to distribution. Located at the high technology Pharmaceutical and Biotechnology Business Park at Grange Castle in Dublin, Takeda Ireland Limited (Grange Castle) is Takeda's first operation with API manufacturing outside Japan.
TIL draws on the expertise of its world-class people, equipment and systems to meet the challenges of competing in our leading edge markets. With a best-in-class quality record, TIL has also focused on operational excellence with all of it’s employees trained in LEAN manufacturing techniques.
A third wing of the Irish operations is known as Takeda Products Ireland Limited and is a dedicated sales and marketing division. This operation is based in Citywest, in the west of Dublin.

At our core, Takeda Ireland is committed to the health and wellbeing of the patients whom we serve – both nationally and globally. We provide treatments for some of the most life threatening illnesses of our time, delivering a quality of life that would have been unthinkable mere decades ago. In many areas of oncology and numerous other serious illnesses, we are redefining what can rightfully be expected by patients in terms of longevity and improvements in quality of life.